USPTO serial 76315456
PFLUEGER
Reviewed by CopyMark Law Group
Reg. 2803805Status 710
- Filing date
- Status date
- Registration date
- Jan 6, 2004
- Examiner
- FRENCH, CURTIS W
- Law office
- POST REGISTRATION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with PFLUEGER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
D-33374 RHEDA-WIEDENBRUCK, DE
D-33374 RHEDA-WIEDENBRUCK, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
RICHARD S. ROBERTS
RICHARD S. ROBERTS ROBERTS & ROBERTS, LLP,ATTORNEYS AT LAWP.O. BOX 484PRINCETON, NJ 08542-0484UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Homeopathic medicines, pharmaceutical preparations, healthcare preparations and nutritional additives for use in the treatment of] abscess, achylia gastrica, acidosis, acne vulgaris, adiposity, adnexitis, adynamia, agranulocytosis, albuminuria, allergies, alopecia, amenorrhoea, amyotrophy, anal fissure, anal pruritus, angina pectoris, angiopathia, anosmia, anuria, [ anxiety,] aphasia, apoplexy, appendicitis, arteriosclerosis, arthritis, arthrosis, ascites, asthenopia, back pain, bechterew's disease, blackheads, blepharitis, bronchial asthma, bronchiectasis, bronchitis, bruise, bursitis, cancer, cardiac asthma, cardiac insufficienca, chillblains, cholangitis, cholecystitis, cholelithiasis choroiditis; circulatory disorders; cirrhosis of the liver, colds, colics, colitis, concussion, conjunctivitis, constipation, contusion, [ impaired coronary circulation,] cough and sneezing, cyctitis, decubitus ulcer, dementia, depression, dermatitis, diabetes mellitus, diarrhea, distorsion diverticulitis, duodenitis, dysmenorrhea, dyspepsia, dyspnea, dystonia, dysuria, eczema, eczema of the auditory channel, endometritis, enuresis, epicondylitis, lateral humeral, erythema, exanthema, exhaustion, extrasystoles, fainting, fatty liver, fever, fibrosis of the liver, flatulence, frostbite, frozen shoulder, gastralgia, gastritis, glomerulonephritis, gout, gravidity, hardening of the mammary gland, hayfever, headache, heartburn, hemorrhoids, hepatitis, hernia of diaphragma, inguinal hernia, incisinal hernia, herpes labialis, hordeolum, hyperacidity, hypercholesterolaemia, hyperemia, hyperhidrosis, hypermenorrhea, hypertension, hysteria, icterus, impaired hearing, impotency, infantile eczema, inflammation, inflammation of the rectum, insomnia, iritis, keratitis, laryngitis, lichens, low immunity, lumbago, luxation, lymphadenitis, mastitis, measles, meniere's disease, menorrhagia, migraine, myalgia, myopia, nausea, nephrolithiasis, nervousness, neuralgia, neurasthenia, neuritis, neurodermitis, osteoporosis, otitis externa, otitis media, ozaena, pancreatitis, paraesthesia of extremities, pemphigus, periostitis, pharyngitis, phlebitis, pneumonia, nasal polyps, prolapsus ani, prostatitis, pruritus, psoriasis, pyelitis, spasms of pylorus, retinitis, rheumatism, rhinitis, roemheld's syndrome, sciatic pain, seborrhea, shingles, sinusitis, spasms, cramps, splenitis, stomach cramps, sycosis barbae, [ tendopathy,] tinnitus, tonsillitis, tracheitis, travel sickness, trigeminal neuralgia, ulcus cruris, ulcus duodeni, ulcus ventriculi, umbilical colics of children, ureteritis, urticaria, vaginitis, varicosis, venous congestions, vertigo, vomitus, warts, weakness of connective tissue, weakness of memory; dietary supplements for medicinal purposes, and food supplements | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 8, 2014 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Jul 3, 2009 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Jul 3, 2009 | PLGL | ASSIGNED TO PARALEGAL | — |
| Jun 30, 2009 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Jun 5, 2007 | CFIT | CASE FILE IN TICRS | — |
| Jan 6, 2004 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Nov 13, 2003 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Nov 10, 2003 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Nov 7, 2003 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| May 7, 2003 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 7, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 7, 2003 | PAPER RECEIVED | — | |
| Dec 16, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 23, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 12, 2001 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Oct 12, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |